Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Mai

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
BMC Cancer|April 21, 2020
Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impactSarah Z Hazell, Nicholas Mai, Wei Fu, et al.
NPJ Breast Cancer|October 18, 2024
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancerNicholas Mai, Carlos H Dos Anjos, Pedram Razavi, et al.
Research Square|May 15, 2024
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast CancerNicholas Mai, Carlos H Dos Anjos, Pedram Razavi, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2016
Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potencyJulie Farand, Nicholas Mai, Jayaraman Chandrasekhar, et al.
Cancer Discovery|November 10, 2025
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and BindingWanyi Chen, Avantika Gupta, Nicholas Mai, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancerJacob A Boyer, Ezra Y Rosen, Malvika Sharma, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancerJacob A Boyer, Malvika Sharma, Madeline A Dorso, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
BMC Cancer|April 21, 2020
Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impactSarah Z Hazell, Nicholas Mai, Wei Fu, et al.
NPJ Breast Cancer|October 18, 2024
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancerNicholas Mai, Carlos H Dos Anjos, Pedram Razavi, et al.
Research Square|May 15, 2024
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast CancerNicholas Mai, Carlos H Dos Anjos, Pedram Razavi, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2016
Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potencyJulie Farand, Nicholas Mai, Jayaraman Chandrasekhar, et al.
Cancer Discovery|November 10, 2025
Trastuzumab Deruxtecan (T-DXd) Resistance via Loss of HER2 Expression and BindingWanyi Chen, Avantika Gupta, Nicholas Mai, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancerJacob A Boyer, Ezra Y Rosen, Malvika Sharma, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancerJacob A Boyer, Malvika Sharma, Madeline A Dorso, et al.
Pageof 2